Dynamic quotes: Off
|
Company Description (as filed with the SEC)
We are a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines consisting of novel therapeutics paired with companion diagnostics. Our mission is to provide patients, physicians and the healthcare system with the medicines, tools and information to transform the approach to care from one based on the identification and treatment of symptoms to one focused on the diagnosis and treatment of illness through a more precise mechanistic understanding of disease. We seek to accomplish our mission by applying our proprietary systems biology-based approach to biomedical research, which we call Network Biology. Our vision is to apply Network Biology to become a global healthcare enterprise that is founded on leading science and driven to deliver integrated healthcare solutions that improve both the quality of outcomes and the efficiency of care. Our initial focus is in the field of oncology. ... More ...
Analyst Info |
|
| Annual EPS Est: | $-1.28 |
| Quarterly EPS Est: | -0.29 |
| PEG Ratio: | -.01 |
|
Mean Recommendation: View Summary / View All |
1 |
Data is provided by Zacks Investment Research
